The mouse tumor cell lines EL4 and RMA display mosaic expression of NK- related and certain other surface molecules and appear to have a common origin

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5094-5102

  Gays, Frances ^a   Unnikrishnan, Meera ^a   Shrestha, Sunil ^a   Fraser, Karen P ^a   Brown, Adam R ^a   Tristram, Colin M G ^a   Chrzanowska Lightowlers, Zosia M A ^a   Brooks, Colin G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; HERMES ANTIGEN; HISTONE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ACETYLATION; ARTICLE; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE SWITCHING; HUMAN; HUMAN CELL; MOSAICISM; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL CULTURE;

EID: 0034657322     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5094     Document Type: Article

References (81)

1. Ljunggren, H. G., and K. Karre. 1990. In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11:237.
2. Lopez-Botet, M., M. Carretero, T. Bellon, J. J. Perez-Villar, M. Llano, and F. Navarro. 1998. The CD94/NKG2 C-type lectin receptor complex. Curr. Top. Microbiol. Immunol. 230:41.
3. Vance, R. E., J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Rautet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841.
4. Takei, F., J. Brennan, and D. L. Mager. 1997. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol. Rev. 155:67.
5. Brown, M. G., A. A. Scalzo, K. Matsumoto, and W. M. Yokoyama. 1997. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol. Rev. 155:53.
6. Raulet, D. H., W. Held, I. Correa, J. R. Dorfman, M. F. Wu, and L. Corral. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155:41.
7. Vance, R. E., and D. H. Raulet. 1998. Toward a quantitative analysis of the repertoire of class 1 MHC-specific inhibitory receptors on natural killer cells. Curr. Top. Macrobiol. Immunol. 230:135.
8. Manoussaka, M. S., R. J. Smith, V. Conlin, J. A. Toomey, and C. G. Brooks. 1998. Fetal mouse NK cell clones are deficient in Ly49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro. J. Immunol. 160:2197.
9. Toomey, J. A., M. Salcedo, L. A. Cotterill, M. M. Millrain, Z. Chrzanowska-Lightowlers, J. Lawry, K. Fraser, F. Gays, J. H. Robinson, S. Shrestha, P. et al. 1999. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets. J. Immunol. 163:3176.
10. Chambers, W. H., N. L. Vujanovic, A. B. DeLeo, M. W. Olszowy, R. B. Herberman, and J. C. Hiserodt. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169:1373.
11. Karlhofer, F. M., and W. M. Yokoyama. 1991. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen: IL-2-activated NK cells possess additional specific stimulation pathways. J. Immunol. 146:3662.
12. Perussia, B. 1998. Fc receptors on natural killer cells. Curr. Top. Microbiol. Immunol. 230:63.
13. Metes, D., L. K. Ernst, W. H. Chambers, A. Sulica, R. B. Herberman, and P. A. Morel. 1998. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcyRIIC gene. Blood 91:2369.
14. Mandelboim, O., P. Malik, D. M. Davis, C. H. Jo, J. E. Boyson, and J. L. Strominger. 1999. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc. Natl. Acad. Sci. USA 96:5640.
15. Siliciano, R. F., J. C. Pratt, R. E. Schmidt, J. Ritz, and E. L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the TI1 sheep erythrocyte binding protein. Nature 317:428.
16. Nandi, D., J. A. Gross, and J. P. Allison. 1994. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152:3361.
17. Carbone, E., G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta. 1997. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185: 2053.
18. Helander, T. S., O. Carpen, O. Turunen, P. E. Kovanen, A. Vaheri, and T. Timonen. 1996. ICAM-2 redistributed by ezrin as a target for killer cells. Nature 382:265.
19. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specitic NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
20. Battistini, L., G. Borsellino, G. Sawicki, F. Poccia, M. Salvetti, G. Ristori, and C. F. Brosnan. 1997. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors. J. Immunol. 159:3723.
21. Carena, I., A. Shamshiev, A. Donda, M. Colonna, and G. D. Libero. 1997. Major histocompatibility complex class 1 molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ stimulated by nonpeptidic ligands. J. Exp. Med. 186:1769.
22. Brennan, J., D. Mager, W. Jefferies, and F. Takei. 1994. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180:2287.
23. + cells. J. Immunol. 160:1158.
24. Wayner, E. A., and C. G. Brooks. 1984. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells. J. Immunol. 132:2135.
25. Tomonari, K. 1988. A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics 28:455.
26. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
27. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
28. Trowbridge, I. S., J. Lesley, R. Schulte, R. Hyman, and J. Trotter. 1982. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 15:299.
29. Nagasawa, R., J. Gross, O. Kanagawa, K. Townsend, L. L. Lamer, J. Chiller, and J. P. Allison. 1987. Identification of a novel T cell surface disulfide-bonded dimer distinct from the α/β antigen receptor. J. Immunol. 138:815.
30. Sentman, C. L., J. Hackett, Jr., V. Kumar, and M. Bennett. 1989. Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J. Exp. Med. 170:191.
31. Mason, L., S. L. Giardina, T. Hecht, J. Ortaldo, and B. J. Mathieson. 1988. LGL-1: a non-polymorphic antigen expressed on a major population of mouse natural killer cells. J. Immunol. 140:4403.
32. Koo, G. C., and J. R. Peppard. 1984. Establishment of monoclonal anti-NK-1.1 antibody. Hybridoma 3:301.
33. Sentman, C. L., J. Hackett, Jr., T. A. Moore, M. M. Tutt, M. Bennett, and V. Kumar. 1989. Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma 8:605.
34. van Meerwijk, J. P., H. Bluthmann, and M. Steinmetz. 1990. T-cell specific rearrangement of T-cell receptor β transgenes in mice. EMBO J. 9:1057.
35. - cells. J. Exp. Med. 179:1957.
36. + NK T cells. J. Immunol. 158:2076.
37. Casanova, J. L., P. Romero, C. Widmann, P. Kourilsky, and J. L. Maryanski. 1991. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodiunt berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. 174:1371.
38. Toomey, J. A., S. Shrestha, S. A. de la Rue, F. Gays, J. H. Robinson, Z. M. Chrzanowska-Lightowlers, and C. G. Brooks. 1998. MHC class I expression protects target cells from lysis by Ly49-dericient fetal NK cells. Eur. J. Immunol. 28:47.
39. Chan, P. Y., and F. Takei. 1986. Expression of a T cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants. J. Immunol. 136:1346.
40. Ryan, J. C., J. Turck, E. C. Niemi, W. M. Yokoyama, and W. E. Seaman. 1992. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J. Immunol. 149:1631.
41. Ravetch, J. V., A. D. Luster, R. Weinshank, J. Kochan, A. Pavlovec, D. A. Portnoy, J. Hulmes, Y. C. Pan, and J. C. Unkeless. 1986. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science 214:718.
42. Perussia, B., M. M. Tutt, W. Q. Qiu, W. A. Kuziel, P. W. Tucker, G. Trinchieri, M. Bennett, J. V. Ravetch, and V. Kumar. 1989. Murine natural killer cells express functional Fey receptor II encoded by the FcγRα gene. J. Exp. Med. 170:73.
43. Bird, A. P. 1986. CpG-rich islands and the function of DNA methylation. Nature 321:209.
44. Jaenisch, R. 1997. DNA methylation and imprinting: why bother? Trends Genet. 13:123.
45. Jones, P. A. 1999. The DNA methylation paradox. Trends Genet. 15:34.
46. Kuo, M. H., and C. D. Allis. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 20:615.
47. Kouzarides, T. 1999. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9:40.
48. Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386.
49. Kronenberg, M., J. Goverman, R. Haars, M. Malissen, E. Kraig, L. Phillips, T. Delovitch, N. Suciu-Foca, and L. Hood. 1985. Rearrangement and transcription of the β-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature 313:647.
50. Shi, Y., A. Kaliyaperumal, L. Lu, S. Southwood, A. Sette, M. A. Michaels, and S. K. Datta. 1998. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor α chain. J. Exp. Med. 187:367.
51. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675.
52. Powis, S. J., A. R. Townsend, E. V. Deverson, J. Bastin, G. W. Butcher, and J. C. Howard. 1991. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354:528.
53. Correa, I., L. Corral, and D. H. Raulet. 1994. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur. J. Immunol. 24:1323.
54. Brossay, L., D. Jullien, S. Cardell, B. C. Sydora, N. Burdin, R. L. Modlin, and M. Kronenberg. 1997. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159:1216.
55. Moingeon, P., J. L. Lucich, D. J. McConkey, F. Letourneur, B. Malissen, J. Kochan, H. C. Chang, H. R. Rodewald, and E. L. Reinherz. 1992. CD3ζ dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc. Natl. Acad. Sci. USA 89:1492.
56. Howard, F. D., P. Moingeon, U. Moebius, D. J. McConkey, B. Yandava, T. E. Gennert, and E. L. Reinherz. 1992. The CD3ζ cytoplasmic domain mediates CD2-induced T cell activation. J. Exp. Med. 176:139.
57. Wegener, A. M., F. Letourneur, A. Hoeveler, T. Brocker, F. Luton, and B. Malissen. 1992. The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 68:83.
58. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:2065.
59. Lerner, A., L. D'Adamio, A. C. Diener, L. K. Clayton, and E. L. Reinherz. 1993. CD3ζ/η/θ locus is colinear with and transcribed antisense to the gene encoding the transcription factor Oct-1. J. Immunol. 151:3152.
60. Sneller, M. C., and K. C. Gunter. 1987. DNA methylation alters chromatin structure and regulates Thy-1 expression in EL-4 T cells. J. Immunol. 138:3505.
61. Kioussis, D., and R. Festenstein. 1997. Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr. Opin. Genet. Dev. 7:614.
62. Siminovitch, L. 1976. On the nature of hereditable variation in cultured somatic cells. Cell 7:1.
63. Holliday, R. 1987. The inheritance of epigenetic defects. Science 238:163.
64. Antequera, F., J. Boyes, and A. Bird. 1990 High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503.
65. + T cell populations. Int. Immunol. 7:1157.
66. - single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor Vβ family. Proc. Natl. Acad. Sci. USA 89:6506.
67. + T cells. J. Exp. Med. 187:2109.
68. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158:5112.
69. + T cells. Eur. J. Immunol. 28:3172.
70. Chiu, Y. H., J. Jayawardena, A. Weiss, D. Lee, S. H. Park, A. Dautry-Varsat, and A. Bendelac. 1999. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189:103.
71. Davodeau, F., M. A. Peyrat, A. Necker, R. Dominici, F. Blanchard, C. Leget, J. Gaschet, P. Costa, Y. Jacques, A. Godard, et al. 1997. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J. Immunol. 158:5603.
72. - thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23:307.
73. + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA 92:11931.
74. Demand, J., M. Bouaboula, A. D. d'Angeac, J. Favero, D. Shire, and P. Casellas. 1992. Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line. J. Cell Physiol. 151:71.
75. Green, W. R. 1980. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen. J. Immunol. 125: 2584.
76. 2-microglobulin transfection to EL-4 mutant cells. J. Exp Med. 175:843.
77. Gomard, E., J. P. Levy, F. Plata, Y. Henin, V. Duprez, A. Bismuth, and T. Reme. 1978. Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirus-induced tumors. Eur. J. Immunol. 8:228.
78. Glynn, J. P., J. L. McCoy, and A. Fefer. 1968. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. Cancer Res. 28:434.
79. Chan, P. Y., and F. Takei. 1989. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J. Immunol. 142:1727.
80. lck. EMBOJ. 11:4877.
81. Old, L. J., E. A. Boyse, and E. Stockert. 1965. The G (Gross) leukemia antigen. Cancer Res. 25:813.